Matthew Rosenberg

Economist
U.S. Food & Drug Administration

Papers:

93 The Impact of Abuse-Deterrent Formulation of Extended-Release OxyContin on Non-Medical Use of Prescription Pain Relievers and Heroin Use

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.